TY - JOUR
T1 - Endpoints for lymphatic filariasis programs
AU - Grady, Caroline A.
AU - De Rochars, Madsen Beau
AU - Direny, Abdel N.
AU - Orelus, Jean Nicolas
AU - Wendt, Joyanna
AU - Radday, Jeanne
AU - Mathieu, Els
AU - Roberts, Jacquelin M.
AU - Streit, Thomas G.
AU - Addiss, David G.
AU - Lammie, Patrick J.
PY - 2007/4
Y1 - 2007/4
N2 - In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs.
AB - In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs.
UR - http://www.scopus.com/inward/record.url?scp=34047153923&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34047153923&partnerID=8YFLogxK
U2 - 10.3201/eid1304.061063
DO - 10.3201/eid1304.061063
M3 - Article
C2 - 17553278
AN - SCOPUS:34047153923
SN - 1080-6040
VL - 13
SP - 608
EP - 610
JO - Emerging infectious diseases
JF - Emerging infectious diseases
IS - 4
ER -